Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 August 2022 | Story Leonie Bolleurs | Photo Francois van Vuuren, iFlair Photography
UFS Sasol Solar car
Team UFS, which has entered its solar-powered vehicle, Lengau (meaning Cheetah in Sesotho), will compete against more than 11 other teams, both local and international. Pictured here is the entire team during one of the road tests at Brandkop in Bloemfontein.

It is almost three years after Team UFS first decided to put a solar-powered vehicle on the road. Within a few days, this dream of participating in the international Sasol Solar Challenge will become a reality when they depart from Carnival City in Johannesburg on 9 September 2022.

For the challenge, the team of ten members will stop at six points between the departure point and the V&A Waterfront in Cape Town, where they will arrive on 16 September 2022.

Completing the estimated distance of 2 500 km

“The team that finishes with the greatest distance covered within the allotted time, will win the challenge,” says Dr Hendrik van Heerden from the UFS Department of Physics and project manager of Team UFS. 

The UFS, which has entered its solar-powered vehicle, Lengau (meaning Cheetah in Sesotho), will compete against more than 11 other teams, both local and international.

Dr Van Heerden’s two main objectives in entering the challenge, are to build a solar-powered vehicle robust enough to complete the estimated distance of 2 500 km during the 2022 Sasol Solar Challenge. Furthermore, he aims to establish capacity in the students and staff through acquired practical knowledge on the management, design, construction, and actual racing of solar-powered vehicles, which is to form the basis for participation in future projects and event competitions. 

Bringing together expertise from the UFS Departments of Physics, Engineering Sciences, Computer Sciences and Informatics, Electronics and Instrumentation, and Geography, the team of 23 started with the construction of their vehicle on 18 October 2021. 

Just over 10 months later and the car is fully functional, already passed a few road tests, and the crew is ready for the big challenge ahead.

The three drivers, Albert Dreyer, Monica van der Walt, Denver de Koker, together with back-up driver Lukas Erasmus, will travel on public roads via a predefined route over eight days, driving every day between 07:30 and 17:00. The aluminium-frame vehicle will weigh up to 370 kg, including the frame, the five solar panels, and the driver, and can reach a maximum speed of 60 km per hour (they aim to average 45 km/hour). 

According to the Sasol Solar Challenge rules and regulations, no driver is allowed to drive for longer than two hours. The capacity of the batteries and the availability of sun will determine how often the drivers will need to stop to recharge the solar batteries. 

Popularising electric vehicle technologies

This is the first time that Team UFS will be participating in the Sasol Solar Challenge. A guardedly optimistic Dr Van Heerden says their goal is to complete the full distance without breakages, and to accumulate as much knowledge and information as possible. With the next Sasol Solar Challenge in two years’ time, they plan to enter again. 

“Our long-term aim is to continually improve on the design, technology, science, and project implementation to participate in events and challenges around ‘green’ energy and relevant technologies. An additional aim is the popularisation of electric vehicle (EV) technologies through outreach programmes,” says Dr Van Heerden. 

Prof Koos Terblans, Head of the Department of Physics, says one of the key benefits of this project was that the group, consisting of personnel and students from different departments, learned to work together as one team. “Together, they worked and made plans to collect and apply the maximum amount of energy. Looking at the bigger picture, they are solving a worldwide problem, that of harvesting and applying energy. I am very excited that they have come this far; this is a first for the university.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept